바로가기메뉴

본문 바로가기 주메뉴 바로가기

Microsatellite Alterations of Plasma DNA in Non Small Cell Lung Cancer

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.58 no.4, pp.352-358










  • Downloaded
  • Viewed

Abstract

keywords
Non-Small Cell Lung cancer, Microsatellite Alteration, Plasma DNA

Reference

1.

(1996) et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. ,

2.

(2001) Circulating nucleic acids in plasma and serum:an overview,

3.

(2000) et al. Microsatellite alterations plasma DNA of primary breast cancer patients. ,

4.

(2002) et al. Allelic imbalance and microsatellite instability in plasma DNA released from polyclonal pancreatic adenocarcinoma.,

5.

(2001) titation of genomic DNA in plasma and serum samples higher concentrations of genomic DNA found in serum than in plasma,

6.

(2004) Death rate statistics of Korea,

7.

(1998) et al. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. ,

8.

(1994) Lung cancer in Korea(1980~1984),

9.

(2001) et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.,

10.

(1999) Pastorino U. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients a prospect for early diagnosis.,

11.

(2003) Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients,

12.

(2004) Detecting lung cancer in plasma with the use of multiple genetic markers.,

13.

(2000) Sidransky D. An overview on the isola� tion and analysis of circulating tumor DNA in plasma and serum,

14.

(2004) Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases.,

15.

(2002) tous polyposis coli promoter methylation analysis in tumor tissue and plasma DNA of patients with lung cancer.,

16.

(Sci2001) Circulating nucleic acids^apoptosis. ,

17.

(2003) Quantification of free circulating DNA as a diagnostic marker in lung cancer.,

18.

(2004) Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy,

Tuberculosis & Respiratory Diseases